Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group. [electronic resource]
Producer: 19950310Description: 934-41 p. digitalISSN:- 0022-5347
- Administration, Intravesical
- Aged
- Aged, 80 and over
- Carcinoma, Transitional Cell -- drug therapy
- Chemotherapy, Adjuvant
- Doxorubicin -- therapeutic use
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Mitomycin -- therapeutic use
- Neoplasm Recurrence, Local -- epidemiology
- Neoplasms, Second Primary -- epidemiology
- Prognosis
- Prospective Studies
- Survival Rate
- Time Factors
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.